The objective of this paper is to evaluate available evidence for each step in autoimmune
encephalitis management and provide expert opinion when evidence is lacking. The paper …

Autoimmune encephalitis defines brain inflammation caused by a misdirected immune
response against self-antigens expressed in the central nervous system. It comprises a …

Epileptogenic triggers are multifactorial and not well understood. Here we aimed to address
the hypothesis that inappropriate pro-inflammatory mechanisms contribute to the …

Abstract Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is the most recognized
form of autoimmune encephalitis. It is characterized by a constellation of neurologic and …

Background and Objectives To determine the real-world use of rituximab in autoimmune
encephalitis (AE) and to correlate rituximab treatment with the long-term outcome. Methods …

Seronegative autoimmune encephalitis is autoimmune encephalitis without any identifiable
pathogenic antibody. Although it is a major subtype of autoimmune encephalitis, many …

Objective To compare acute treatment responses and long-term outcome in leucine-rich
glioma-inactivated 1 (LGI1) antibody encephalitis. Methods Retrospective case series of 118 …

The objective of this paper is to evaluate available evidence for each step in autoimmune
encephalitis management and provide expert opinion when evidence is lacking. The paper …

The field of autoimmune epilepsy has evolved substantially in the last few decades with
discovery of several neural autoantibodies and improved mechanistic understanding of …

A rapidly expanding and clinically distinct group of CNS diseases are caused by pathogenic
autoantibodies that target neuroglial surface proteins. Despite immunotherapy, patients with …